Stephanou Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
If the program is approved and implemented, weight-loss drug coverage would begin in January 2027
Personal or family history of medullary thyroid cancer or MEN2 syndrome is an absolute contraindication for semaglutide
While the combination is generally safe for many, certain individuals need to exercise extra caution or may not be eligible for this specific combination
Take the next step with Ivologist
Blood donation generally does not disqualify common diabetes treatments, including insulin, metformin, and GLP-1 medications such as Ozempic, Mounjaro, Zepbound, and Rybelsus